AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7128665 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 66 mg noscapine
Number of subjects: 5
Study 7128665 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 150 mg noscapine (rapidly dissolving tablets)
Number of subjects: 5
Study 7128665 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 150 mg noscapine (ion exchange resin-bound tablet)
Number of subjects: 5
Study 28902067 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted prevention program
Number of subjects: 1353
Study 28902067 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined prevention program
Number of subjects: 1353
Study 26682500 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg dapagliflozin and 500 mg metformin XR FDC
Number of subjects: 129
Study 26682500 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg dapagliflozin and 1000 mg metformin XR FDC
Number of subjects: 129
Study 26682500 — intervention group
Group type: COMPARATOR
Intervention: Control group (individual components of dapagliflozin and metformin XR)
Number of subjects: 129
Study 25575802 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean Arterial Pressure (MAP)
Number of subjects: 2782
Study 25575802 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 2782
Study 25575802 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 2782
Study 25575802 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Pressure (PP)
Number of subjects: 2782
Study 22038376 — intervention group
Group type: EXPERIMENTAL
Intervention: MDPC Web site resources
Number of subjects: 3478
Study 22038376 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire‐9 (PHQ‐9)
Number of subjects: 3478
Study 20524710 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA)
Number of subjects: 1000
Study 20524710 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CGA)
Number of subjects: 1000
Study 20524710 — intervention group
Group type: EXPERIMENTAL
Intervention: CGA by study physicians
Number of subjects: 1000
Study 20524710 — intervention group
Group type: EXPERIMENTAL
Intervention: CGA initiated drugs
Number of subjects: 1000
Study 20524710 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs terminated by study physicians
Number of subjects: 1000
Study 18719936 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed rest with resistive vibration exercise (BR-RVE)
Number of subjects: 16
Study 18719936 — intervention group
Group type: COMPARATOR
Intervention: Bed rest (BR-Ctrl)
Number of subjects: 16
Study 16671160 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontotemporal Dementia (FTD)
Number of subjects: 74
Study 16671160 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic Dementia (SD)
Number of subjects: 74
Study 16671160 — intervention group
Group type: COMPARATOR
Intervention: Alzheimer-type Dementia (AD)
Number of subjects: 74
Study 12792162 — intervention group
Group type: EXPERIMENTAL
Intervention: Low serum albumin levels
Number of subjects: 2771
Study 12792162 — intervention group
Group type: EXPERIMENTAL
Intervention: Confusion
Number of subjects: 2771
Study 12792162 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal incontinence
Number of subjects: 2771
Study 12792162 — intervention group
Group type: EXPERIMENTAL
Intervention: Do Not Resuscitate (DNR) order
Number of subjects: 2771
Study 12792162 — intervention group
Group type: EXPERIMENTAL
Intervention: Malnourished status
Number of subjects: 2771
Study 12792162 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary catheter requirement
Number of subjects: 2771
Study 10916803 — intervention group
Group type: EXPERIMENTAL
Intervention: Active antihypertensive therapy
Number of subjects: 13
Study 10916803 — intervention group
Group type: COMPARATOR
Intervention: Non-therapeutic control
Number of subjects: 13
Study 8974553 — intervention group
Group type: EXPERIMENTAL
Intervention: Program to improve recording of drug prescribing
Number of subjects: 463
Study 8460608 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% olive oil plus 3% soybean oil emulsion
Number of subjects: 6
Study 8460608 — intervention group
Group type: COMPARATOR
Intervention: 20% soybean oil emulsion
Number of subjects: 6
Study 3884916 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospice care
Number of subjects: 0
Study 3884916 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 3884916 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospice care for significant others (SOs)
Number of subjects: 0
Study 3884916 — intervention group
Group type: COMPARATOR
Intervention: Control SOs
Number of subjects: 0
Study 30810481 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-layer wound sealing (waterproof topical dressing as first layer and antimicrobial drape as second layer)
Number of subjects: 20
Study 30810481 — intervention group
Group type: COMPARATOR
Intervention: Control (uninjured hand)
Number of subjects: 20
Study 29340913 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills TO Manage Pain (STOMP)
Number of subjects: 22
Study 29340913 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 22
Study 27000329 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective memory intervention
Number of subjects: 0
Study 27000329 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 24553022 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (10 mg)
Number of subjects: 40
Study 24553022 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine + Sufentanil (7.5 mg + 5 μg)
Number of subjects: 40
Study 22951783 — intervention group
Group type: EXPERIMENTAL
Intervention: Russian β-interferon-1b bioanalogue (infibeta)
Number of subjects: 122
Study 22951783 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 122
Study 22951783 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 122
Study 20534124 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU/week of intravenous epoietin alfa or beta (or equivalent ESA)
Number of subjects: 2204
Study 20534124 — intervention group
Group type: COMPARATOR
Intervention: 18000 IU/week of intravenous epoietin alfa or beta (or equivalent ESA)
Number of subjects: 2204
Study 20534124 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life assessment
Number of subjects: 2204
Study 20534124 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost assessment
Number of subjects: 2204
Study 18398651 — intervention group
Group type: EXPERIMENTAL
Intervention: Toupet 1.5-cm wrap
Number of subjects: 153
Study 18398651 — intervention group
Group type: EXPERIMENTAL
Intervention: Toupet 3-cm wrap
Number of subjects: 153
Study 18398651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen 1.5-cm wrap
Number of subjects: 153
Study 18398651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen 3-cm wrap
Number of subjects: 153
Study 15865094 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU/PSK therapy
Number of subjects: 87
Study 15865094 — intervention group
Group type: COMPARATOR
Intervention: 5-FU alone
Number of subjects: 87
Study 14646711 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal-on-metal bearings for total hip arthroplasty
Number of subjects: 0
Study 14646711 — intervention group
Group type: COMPARATOR
Intervention: Conventional metal-on-polyethylene bearings
Number of subjects: 0
Study 10373231 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 to 10 mg/d)
Number of subjects: 47
Study 10373231 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilnidipine (10 to 20 mg/d)
Number of subjects: 47
Study 10373231 — intervention group
Group type: COMPARATOR
Intervention: Normotensive subjects (control group)
Number of subjects: 47
Study 8675100 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholate 500 mg/day
Number of subjects: 0
Study 8675100 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholate 1000 mg/day
Number of subjects: 0
Study 8675100 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholate 1500 mg/day
Number of subjects: 0
Study 8675100 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholate (all doses)
Number of subjects: 0
Study 8675100 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholate (highest dose)
Number of subjects: 0
Study 8675100 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholate
Number of subjects: 0
Study 1378114 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg bemetizide (n = 18)
Number of subjects: 36
Study 1378114 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg bemetizide plus 50 mg triamterene (n = 18)
Number of subjects: 36
Study 1378114 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg bemetizide (n = 16)
Number of subjects: 36
Study 1378114 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg bemetizide plus 20 mg triamterene (n = 16)
Number of subjects: 36
Study 1378114 — intervention group
Group type: EXPERIMENTAL
Intervention: bemetizide group
Number of subjects: 36
Study 3904390 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study 3904390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30309256 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic window mural
Number of subjects: 90
Study 30309256 — intervention group
Group type: EXPERIMENTAL
Intervention: Tree window mural
Number of subjects: 90
Study 30309256 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 90
Study 29485746 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional cash transfer (CCT)
Number of subjects: 2448
Study 26271367 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative state anxiety measured using the State‐Trait Anxiety Inventory
Number of subjects: 86
Study 26271367 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent predictors of postoperative delirium
Number of subjects: 86
Study 24781721 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education (active management and postural hygiene) combined with lumbar strengthening exercise
Number of subjects: 49
Study 24781721 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 49
Study 19895595 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral enteral nutrition supplement plus supplemental parenteral nutrition (PN+)
Number of subjects: 82
Study 19895595 — intervention group
Group type: COMPARATOR
Intervention: Oral enteral nutrition supplement (PN-)
Number of subjects: 82
Study 16274150 — intervention group
Group type: EXPERIMENTAL
Intervention: Early placement of single-tooth acid-etched Osseotite implant (average of 10 days after extraction)
Number of subjects: 45
Study 16274150 — intervention group
Group type: COMPARATOR
Intervention: Delayed placement of single-tooth acid-etched Osseotite implant (average of 3 months after extraction)
Number of subjects: 45
Study 16274150 — intervention group
Group type: EXPERIMENTAL
Intervention: Early placement
Number of subjects: 45
Study 16274150 — intervention group
Group type: COMPARATOR
Intervention: Delayed placement
Number of subjects: 45
Study 16274150 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 45
Study 12066728 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen 25 mg tds for 24 h before and 48 h after surgery
Number of subjects: 30
Study 9563808 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural treatment
Number of subjects: 54
Study 9563808 — intervention group
Group type: COMPARATOR
Intervention: Non-focused treatment
Number of subjects: 54
Study 7922829 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute myocardial infarction patients
Number of subjects: 71
Study 7922829 — intervention group
Group type: COMPARATOR
Intervention: Healthy male controls
Number of subjects: 71
Study 3409309 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioxaglate
Number of subjects: 32
Study 3409309 — intervention group
Group type: COMPARATOR
Intervention: Diatrizoate
Number of subjects: 32
Study 11377126 — intervention group
Group type: EXPERIMENTAL
Intervention: Donation promise letter
Number of subjects: 219
Study 11377126 — intervention group
Group type: COMPARATOR
Intervention: Standard covering letter
Number of subjects: 219
Study 30707709 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Transfer Decision Difficulty Scale (PTDDS)
Number of subjects: 2
Study 30242221 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy (BLT)
Number of subjects: 24
Study 30242221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 30242221 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 24
Study 27442346 — intervention group
Group type: EXPERIMENTAL
Intervention: POLST (experimental)
Number of subjects: 0
Study 27442346 — intervention group
Group type: COMPARATOR
Intervention: Control (no POLST)
Number of subjects: 0
Study 24960395 — intervention group
Group type: EXPERIMENTAL
Intervention: NuSmile crowns
Number of subjects: 14
Study 24960395 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinder Krowns
Number of subjects: 14
Study 24960395 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 14
Study 24960395 — intervention group
Group type: EXPERIMENTAL
Intervention: Both crown types
Number of subjects: 14
Study 22734802 — intervention group
Group type: EXPERIMENTAL
Intervention: Hartcoach‐programme plus usual care
Number of subjects: 400
Study 22734802 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 400
Study 20459818 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolapse surgery combined with anti-incontinence surgery (concomitant surgery)
Number of subjects: 450
Study 20459818 — intervention group
Group type: COMPARATOR
Intervention: Prolapse surgery only
Number of subjects: 450
Study 17684102 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-h fast
Number of subjects: 25
Study 17684102 — intervention group
Group type: EXPERIMENTAL
Intervention: 48-h fast
Number of subjects: 25
Study 15241751 — intervention group
Group type: EXPERIMENTAL
Intervention: 90, 180, or 360U of BTX
Number of subjects: 91
Study 15241751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 11755938 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals rich in heated safflower oil (60 g)
Number of subjects: 16
Study 11755938 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals rich in heated olive oil (60 g)
Number of subjects: 16
Study 11755938 — intervention group
Group type: COMPARATOR
Intervention: Meals containing unheated safflower oil (US)
Number of subjects: 16
Study 11755938 — intervention group
Group type: COMPARATOR
Intervention: Meals containing unheated olive oil (UO)
Number of subjects: 16
Study 9640058 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline treatment (1200 mg i.v. for the first 5 days, followed by 800 mg orally for subsequent days for 30 days)
Number of subjects: 107
Study 9640058 — intervention group
Group type: COMPARATOR
Intervention: Typical treatment
Number of subjects: 107
Study 8207318 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (100 U/ml) in sterile saline administered twice daily for 8 weeks
Number of subjects: 8
Study 8207318 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterile saline) administered twice daily for 8 weeks
Number of subjects: 8
Study 2492464 — intervention group
Group type: EXPERIMENTAL
Intervention: Small inspiratory resistive load R1 (2.5 cmH2O L/s)
Number of subjects: 0
Study 2492464 — intervention group
Group type: EXPERIMENTAL
Intervention: Small inspiratory resistive load R2 (5.2 cmH2O L/s)
Number of subjects: 0
Study 2492464 — intervention group
Group type: COMPARATOR
Intervention: Unloaded breathing (R0)
Number of subjects: 0
Study 2492464 — intervention group
Group type: COMPARATOR
Intervention: Healthy nonsmokers (control group)
Number of subjects: 0
Study 2492464 — intervention group
Group type: EXPERIMENTAL
Intervention: General testing conditions
Number of subjects: 0
Study 1153996 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs that presumably improve the clearance of diseased airways
Number of subjects: 0
Study 1153996 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31722294 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made daily routine (CDR)
Number of subjects: 36
Study 31722294 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise (HE)
Number of subjects: 36
Study 31722294 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 36
Study 28225450 — intervention group
Group type: EXPERIMENTAL
Intervention: Small incentives for attending timely clinic visits or achieving high medication adherence (US $1.50 awarded through a drawing).
Number of subjects: 155
Study 28225450 — intervention group
Group type: COMPARATOR
Intervention: Control group received the usual standard of care.
Number of subjects: 155
Study 25522762 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1 and standard care (n=30)
Number of subjects: 90
Study 25522762 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 2 and standard care (n=30)
Number of subjects: 90
Study 25522762 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (n=30)
Number of subjects: 90
Study 24027944 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestures conveying accurate information about the scene
Number of subjects: 0
Study 24027944 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestures conveying false, misleading information
Number of subjects: 0
Study 24027944 — intervention group
Group type: EXPERIMENTAL
Intervention: Live interview with misleading gestures
Number of subjects: 0
Study 21483401 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA) 600 mg or 1200 mg daily for 30 days
Number of subjects: 0
Study 21483401 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study 18649369 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 0
Study 18649369 — intervention group
Group type: EXPERIMENTAL
Intervention: fentanyl
Number of subjects: 0
Study 18649369 — intervention group
Group type: COMPARATOR
Intervention: midazolam and propofol
Number of subjects: 0
Study 16445786 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate gel
Number of subjects: 67
Study 16445786 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate lotion
Number of subjects: 67
Study 16445786 — intervention group
Group type: EXPERIMENTAL
Intervention: BP/erythromycin gel
Number of subjects: 67
Study 16445786 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin/zinc solution
Number of subjects: 67
Study 16445786 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall satisfaction ranking
Number of subjects: 67
Study 16445786 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 67
Study 14740155 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block (0.375% Bupivacaine)
Number of subjects: 50
Study 14740155 — intervention group
Group type: COMPARATOR
Intervention: Intraarticular local anaesthetic injection (Bupivacaine)
Number of subjects: 50
Study 11014397 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-format self-care intervention
Number of subjects: 1448
Study 9349159 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mm beam diameter (26 micrograms, n = 10)
Number of subjects: 50
Study 9349159 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mm beam diameter (42 micrograms, n = 10)
Number of subjects: 50
Study 9349159 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mm beam diameter (62 micrograms, n = 10)
Number of subjects: 50
Study 9349159 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mm beam diameter (78 micrograms, n = 10)
Number of subjects: 50
Study 9349159 — intervention group
Group type: EXPERIMENTAL
Intervention: multizone treatment (62 micrograms, n = 10)
Number of subjects: 50
Study 9349159 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated eyes)
Number of subjects: 50
Study 8315258 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids
Number of subjects: 17
Study 8315258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 3713102 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic beta-receptor blockade
Number of subjects: 11
Study 3713102 — intervention group
Group type: COMPARATOR
Intervention: Untreated control study
Number of subjects: 11
Study 30150567 — intervention group
Group type: EXPERIMENTAL
Intervention: LTE mobile phone EMF exposure
Number of subjects: 0
Study 30150567 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 0
Study 27042334 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-initiated appointments
Number of subjects: 131
Study 24571603 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure therapy (AAT) for 4 weeks
Number of subjects: 22
Study 22717890 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin 80-120 μg
Number of subjects: 80
Study 20484124 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 44
Study 20484124 — intervention group
Group type: COMPARATOR
Intervention: Structured Diabetes Education (SDE)
Number of subjects: 44
Study 18772643 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg and hydrochlorothiazide 25 mg (T80/H25)
Number of subjects: 713
Study 18772643 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan 80 mg and hydrochlorothiazide 12.5 mg (T80/H12.5)
Number of subjects: 713
Study 16033295 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreous pegaptanib 0.3 mg
Number of subjects: 1208
Study 16033295 — intervention group
Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 1208
Study 16033295 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreous pegaptanib 0.3-3 mg
Number of subjects: 1208
Study 12023168 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 82
Study 12023168 — intervention group
Group type: COMPARATOR
Intervention: Low energy diet
Number of subjects: 82
Study 10530259 — intervention group
Group type: EXPERIMENTAL
Intervention: Single visit treatment without calcium hydroxide
Number of subjects: 3
Study 10530259 — intervention group
Group type: EXPERIMENTAL
Intervention: Single visit treatment with calcium hydroxide
Number of subjects: 3